NDUFAF4P1: A Drug Target / Disease Biomarker (G100306975)

Target Name: NDUFAF4P1

NCBI ID: G100306975

NDUFAF4P1

Other Name(s): NADH:ubiquinone oxidoreductase complex assembly factor 4 pseudogene 1

NDUFAF4P1: A Drug Target / Disease Biomarker

NDUFAF4P1 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the N-cadherin gene family, which is known for its role in cell-cell adhesion and tissue organization.NDUFAF4P1 has been identified as a potential drug target or biomarker due to its unique structure and expression pattern.

The N-cadherin gene family consists of four different isoforms, which are different in their N-terminus and other features.NDUFAF4P1 is the latest isoform to be discovered in the family, and it is characterized by a unique N-terminus that is rich in conserved amino acids, such as alanine, aspartic acid, and glutamic acid. This specific N-terminus is unique among the other isoforms of the N-cadherin gene family, and it is expected to play a crucial role in the function of the protein.

NDUFAF4P1 is a transmembrane protein, which means that it spans the cell membrane and is involved in various signaling pathways. It is part of the cadherin signaling pathway, which is a well-established framework for cell-cell adhesion and tissue organization. The cadherin signaling pathway is critical for many physiological processes in the body, including cell growth, differentiation, and tissue development.

NDUFAF4P1 is also involved in the regulation of various cellular processes, including cell signaling, cell migration, and cell adhesion. Its unique N-terminus and other features make it a promising candidate for drug targeting or biomarker development.

In addition to its role in cell signaling and adhesion, NDUFAF4P1 is also involved in the regulation of various cellular processes that are critical for tissue structure and function. It is a member of the PDGFR signaling pathway, which is responsible for the regulation of cell proliferation, survival, and angiogenesis.

PDGF signaling is a critical factor in the development and maintenance of tissues and organs, and it is involved in many physiological processes, including embryonic development, tissue repair, and regeneration. The PDGFR signaling pathway is a well-established target for many drugs, including anti-cancer drugs, and it is expected that NDUFAF4P1 will be a new drug target in the future.

NDUFAF4P1 is also involved in the regulation of the Wnt signaling pathway, which is responsible for the regulation of cell growth, differentiation, and angiogenesis. The Wnt signaling pathway is critical for the development and maintenance of tissues and organs, and it is a well-established target for many drugs, including anti-cancer drugs.

The Wnt signaling pathway is also involved in the regulation of many cellular processes that are critical for embryonic development, including the development and maintenance of neural networks. NDUFAF4P1 is a key regulator of the Wnt signaling pathway, and its dysfunction is expected to contribute to the development of various diseases, including cancer.

In conclusion, NDUFAF4P1 is a unique and promising protein that is involved in various signaling pathways. Its N-terminus and other features make it a potential drug target or biomarker, and its involvement in the regulation of cell signaling, adhesion, and tissue structure and function make it a valuable tool for the development of new therapies. Further research is needed to fully understand the function of NDUFAF4P1 and its potential as a drug target or biomarker.

Protein Name: NADH:ubiquinone Oxidoreductase Complex Assembly Factor 4 Pseudogene 1

The "NDUFAF4P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDUFAF4P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets